A股異動丨玻璃概念股大漲 玻璃期貨再度封板 刷新上市以來歷史高點
格隆匯8月3日丨玻璃概念股大漲,南玻A漲停,福耀玻璃逼近漲停,北玻股份漲超6%。今日玻璃期貨再度封板,刷新上市以來歷史高點。現貨方面,8月3日,中國玻璃綜合指數1148.11點,環比上漲8.77點。從產銷情況來看,全國大範圍降雨並未對廠庫去庫產生太大影響,各大主產區銷售情況依然較好。現貨漲價情緒再度點燃,多個廠家上調報價,目前除華南地區外其餘地區原片價格均已超過去年同期。隨着傳統需求旺季的臨近,生產企業報價上漲的速度和幅度明顯加快,為後期旺季市場預熱。貿易商和加工企業也適量增加了備貨速度,以期在旺季時候有足夠的玻璃使用。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.